MedTrace Logo

Evaluation of Moderate to Severe Influenza Outcomes in Children

NCT02979626 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1478

Last updated 2021-02-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to determine whether moderate-severe endpoints (including high fever, lower respiratory tract disease, acute otitis media, or serious extra-pulmonary complications) were predictive of hospitalization, intensive care admission, antibiotic use and other complications in children under 8 years of age.

Conditions

  • Influenza
  • Otitis Media
  • Lower Resp Tract Infection
  • Encephalitic Infection
  • Myositis Viral
  • Fever

Interventions

PROCEDURE

Respiratory nasal swab

Nasal swabs will be obtained for testing by the study nurses. If a respiratory sample has already been collected as part of routine clinical care, this will replace the study collection, and no additional testing will be required.

Sponsors & Collaborators

  • GlaxoSmithKline

    collaborator INDUSTRY

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Edwin J Asturias, MD · University of Colorado, Denver

  • Suchitra Rao, MD · University of Colorado, Denver

Eligibility

Min Age
6 Months
Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-30
Primary Completion
2018-05-04
Completion
2018-05-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02979626 on ClinicalTrials.gov